Monograph Details
|
|
Central Nervous System
> Insomnia
|
|
SLEEPINAL |
| Manufacturer |
|
Blairex Laboratories |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Hypnotic (anticholinergic). |
| Generic Name |
|
Diphenhydramine HCl 50mg; softgels; caps. |
| Also |
|
• SLEEPINAL MINI-TABS
|
| Indications |
|
Short-term (≤ 2 weeks) treatment of insomnia. |
| Children |
Not recommended.
|
| Adults |
|
50mg at bedtime. |
| Precautions |
|
Asthma. Lower respiratory disorders. Glaucoma. Hyperthyroidism. Hypertension. Cardiovascular disease. GI or urinary obstruction. Pregnancy. Nursing mothers. |
| Interactions |
|
Potentiates CNS depression with alcohol, other CNS depressants. Concomitant diphenhydramine products (including topicals): not recommended. Additive effects with other other anticholinergics. |
| Adverse Reactions |
|
Drowsiness, dizziness, anticholinergic effects, paradoxical excitement. |
| How Supplied |
Caps, softgels—16
Tabs—32 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
